OpenSAFELY Vaccine Coverage Report

AstraZeneca / Priority Group 5

Data from combined, up to 2021-03-17.

Vaccinated at 2021-03-17 (%) Vaccinated at 2021-03-17 (n) Population Vaccinated at 2021-03-10 (%) Vaccinated in past week (%)
Overall - 59.4% 1,467,921 2,472,862 57.6% 1.7%
Sex Female 59.3% 747,551 1,261,582 57.6% 1.6%
Male 59.5% 720,370 1,211,280 57.7% 1.8%
Ethnicity White - British 62.1% 899,451 1,448,937 60.5% 1.6%
White - Irish 56.2% 8,785 15,624 54.9% 1.3%
White - Any other White background 43.6% 34,503 79,226 42.0% 1.5%
Mixed - White and Black Caribbean 41.2% 1,309 3,178 38.8% 2.4%
Mixed - White and Black African 41.4% 1,064 2,569 39.5% 1.9%
Mixed - White and Asian 52.9% 1,351 2,555 51.2% 1.6%
Mixed - Any other mixed background 46.5% 2,303 4,949 44.7% 1.8%
Asian or Asian British - Indian 53.3% 26,831 50,323 52.1% 1.2%
Asian or Asian British - Pakistani 46.3% 11,578 25,004 43.8% 2.5%
Asian or Asian British - Bangladeshi 53.8% 3,332 6,195 51.1% 2.7%
Asian or Asian British - Any other Asian background 48.9% 10,990 22,463 47.5% 1.4%
Black or Black British - Caribbean 38.4% 5,747 14,959 36.0% 2.4%
Black or Black British - African 39.0% 5,950 15,267 36.5% 2.5%
Black or Black British - Any other Black background 42.0% 1,533 3,647 39.9% 2.1%
Other ethnic groups - Chinese 47.8% 4,501 9,408 46.2% 1.6%
Other ethnic groups - Any other ethnic group 43.0% 5,698 13,258 41.3% 1.7%
Patients with any other ethnicity code 59.3% 194,341 327,453 57.5% 1.9%
Ethnicity not stated 58.3% 8,799 15,085 56.4% 1.9%
Ethnicity not recorded 58.1% 239,757 412,664 56.2% 1.9%
Ethnicity (broad categories) White 61.1% 942,753 1,543,801 59.5% 1.6%
Mixed 45.6% 6,041 13,258 43.6% 2.0%
South Asian 50.7% 52,759 103,999 49.1% 1.6%
Black 39.1% 13,237 33,887 36.7% 2.4%
Other 45.1% 10,213 22,666 43.4% 1.7%
Unknown 58.6% 442,911 755,216 56.8% 1.9%
Index of Multiple Deprivation 1 (most deprived) 53.6% 197,631 368,403 51.1% 2.6%
2 57.0% 252,308 442,505 54.9% 2.1%
3 59.6% 312,641 524,734 57.9% 1.7%
4 61.4% 338,716 551,642 60.0% 1.4%
5 (least deprived) 62.8% 354,144 563,983 61.6% 1.2%
Unknown 57.8% 12,460 21,560 55.9% 1.9%
Clinical Risk Groups Patients in Any Clinical Risk Group 59.9% 542,556 905,709 58.2% 1.7%
Patients with Immunosuppression 60.6% 22,834 37,674 59.1% 1.5%
Patients with CKD 60.3% 70,385 116,683 58.7% 1.6%
Patients who have Chronic Respiratory Disease 60.0% 57,939 96,572 58.2% 1.8%
Patients with Diabetes 59.2% 192,563 325,458 57.5% 1.7%
Patients with Chronic Liver disease 59.0% 43,400 73,591 57.2% 1.7%
Patients with CNS Disease (including Stroke/TIA) 61.0% 82,404 135,163 59.1% 1.9%
Patients with Chronic heart disease 60.5% 227,213 375,452 58.9% 1.7%
Patients with Asplenia or Dysfunction of the Spleen 62.0% 8,778 14,168 60.7% 1.2%
Patients with Wider Learning Disability 59.8% 3,472 5,810 55.2% 4.6%
Patients with Severe Mental Health 54.9% 13,034 23,758 52.0% 2.9%
Other Groups Patients with Morbid Obesity 59.7% 46,620 78,113 57.7% 2.0%
Patients who are pregnant 61.1% 154 252 58.3% 2.8%